Upgrade to SI Premium - Free Trial

Molina Healthcare Reports Fourth Quarter and Year-End 2019 Financial Results

February 10, 2020 4:15 PM

Introduces Full Year 2020 Earnings Guidance

LONG BEACH, Calif.--(BUSINESS WIRE)-- Molina Healthcare, Inc. (NYSE: MOH) today reported net income for the fourth quarter of 2019 of $168 million, or $2.67 per diluted share, compared to net income of $201 million, or $3.01 per diluted share, for the fourth quarter of 2018. The Company also reported net income for the year ended December 31, 2019, of $737 million, or $11.47 per diluted share, compared to net income of $707 million, or $10.61 per diluted share, for the year ended December 31, 2018. Financial results for the fourth quarter and full year 2019 are summarized below:

Three Months Ended

Year Ended

December 31,

December 31,

2019

2018

2019

2018

(In millions, except per share results)

Premium Revenue

$

4,123

$

4,438

$

16,208

$

17,612

Total Revenue

$

4,274

$

4,664

$

16,829

$

18,890

Pre-Tax Income

$

222

$

256

$

972

$

999

Net Income

$

168

$

201

$

737

$

707

EPS – Diluted

$

2.67

$

3.01

$

11.47

$

10.61

MCR

86.0

%

85.1

%

85.8

%

85.9

%

G&A Ratio

8.0

%

7.2

%

7.7

%

7.1

%

Pre-Tax Margin

5.2

%

5.5

%

5.8

%

5.3

%

Effective Tax Rate

24.3

%

21.4

%

24.2

%

29.2

%

After-Tax Margin

3.9

%

4.3

%

4.4

%

3.7

%

Highlights include:

Joe Zubretsky, president and CEO, said, “We are pleased with our fourth quarter and full year results. We improved our Medicaid and Medicare margins and achieved exceptional Marketplace margins. Overall, we delivered 4.4 percent after-tax margins and earnings per share growth of 8 percent.” Mr. Zubretsky continued, “Going forward, 2020 represents an important year in our pivot to growth strategy with a return to top-line growth. Each of our three business lines are well positioned to grow in 2020 and beyond.”

Premium Revenue

Premium revenue for the fourth quarter of 2019 decreased 7.1% to $4.1 billion compared to $4.4 billion for the fourth quarter of 2018, which was in line with the Company’s expectations.

For the year ended December 31, 2019, premium revenue decreased 8.0% to $16.2 billion, from $17.6 billion for the comparable period in 2018. For both periods, the lower premium revenue is primarily a result of previously announced losses of Medicaid membership in New Mexico and Florida.

Medical Care Ratio

The consolidated MCR for the fourth quarter of 2019 increased to 86.0%, compared to 85.1% for the fourth quarter of 2018, primarily due to the increased Marketplace MCR. Prior period reserve development in the quarter was not material.

The MCR for the year ended December 31, 2019, improved to 85.8%, compared to 85.9% for the comparable period in 2018, due to a combination of the following:

General and Administrative Expense Ratio

General and administrative expenses were 8.0% of total revenues for the fourth quarter of 2019, compared to 7.2% for the fourth quarter of 2018.

For the year ended December 31, 2019, the G&A ratio was 7.7%, compared to 7.1% for the comparable prior-year period. In both periods, the year-over-year increases are due mainly to the year-over-year decline in total revenues.

Interest Expense

Interest expense was $20 million for the fourth quarter of 2019, compared to $24 million for the fourth quarter of 2018. The decline was due to the repayment of convertible notes in 2019.

Balance Sheet

Cash and investments at the parent company amounted to $997 million as of December 31, 2019, compared to $796 million as of September 30, 2019.

For the fourth quarter of 2019, the parent company received $305 million of dividends from the regulated health plan subsidiaries.

The Company repaid $240 million of principal on the convertible notes in 2019. The impact of capital deployment actions in 2019 resulted in lower interest expense, a net gain on repayment of the convertible notes and a lower share count.

In early December 2019, the Company's board of directors authorized the purchase of up to $500 million in aggregate of the Company's common stock. Pursuant to a 10b5-1 trading plan, under this authorization the Company purchased approximately 400,000 shares for $54 million through December 31, 2019, and through February 7th, the Company has purchased in total approximately 1.9 million shares for $257 million.

Cash Flow

Operating cash flows for the year ended December 31, 2019, amounted to $427 million and were higher compared to the year ended December 31, 2018, primarily due to the normal fluctuations in timing of premium receipts.

Outlook

The Company issued its full year 2020 earnings guidance, including GAAP earnings per diluted share of $11.20 - $11.70 and premium revenue growth of 7.4%.

Full year guidance highlights:

Full year guidance reflects the following:

Full Year 2020 Guidance (1)

Premium Revenue

~$17.4B

Medicaid

~$13.3B

Medicare

~$2.5B

Marketplace

~$1.6B

Premium Tax Revenue

~$565M

Health Insurer Fees Reimbursed

~$280M

Total Revenue

~$18.3B

Interest Expense

~$85M

Net Income

$674M - $704M

EPS - Diluted

$11.20 - $11.70

Diluted Shares

~60.2M

Total Membership

~3.4M

Medicaid and Medicare

~3.1M

Marketplace

~310K

Ratios:

MCR

86.2% - 86.4%

G&A Ratio

~7.2%

Effective Tax Rate

30.8% - 31.1%

After-Tax Margin

3.7% - 3.8%

Medicaid

3.2% - 3.4%

Medicare

5.6% - 5.7%

Marketplace

4.7% - 4.9%

___________________________

(1) All amounts are rounded and approximations.

Press Release Format

In an effort to streamline its earnings release, beginning in the first quarter of 2020, the Company will report its financial data by government program as seen on page 9, and schedules on pages 14 - 20 will no longer be published.

Conference Call

Management will host a conference call and webcast to discuss Molina Healthcare’s fourth quarter and year-end 2019 results at 8:00 a.m. Eastern time on Tuesday, February 11, 2020. The number to call for the interactive teleconference is (877) 883-0383 and the confirmation number is 6197632. A telephonic replay of the conference call will be available through Tuesday, February 18, 2020, by dialing (877) 344-7529 and entering confirmation number 10137536. A live audio broadcast of this conference call will be available on Molina Healthcare’s website, molinahealthcare.com. A 30-day online replay will be available approximately an hour following the conclusion of the live broadcast.

About Molina Healthcare

Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. Through its locally operated health plans, Molina Healthcare served approximately 3.3 million members as of December 31, 2019. For more information about Molina Healthcare, please visit molinahealthcare.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This earnings release contains forward-looking statements regarding the Company’s 2020 guidance, as well as its plans, expectations, and anticipated future events. Actual results could differ materially due to numerous known and unknown risks and uncertainties. Those risks and uncertainties are discussed in the section entitled “Risk Factors,” and the section entitled “Forward-Looking Statements” in our Annual Report on Form 10-K for the year ended December 31, 2018, and our most recent Quarterly Report on Form 10-Q for the quarter ended September 30, 2019, which are on file with the SEC. Additional information will also be set forth in our Annual Report on Form 10-K for the year ended December 31, 2019.

These reports can be accessed under the investor relations tab of the Company’s website or on the SEC’s website at sec.gov. Given these risks and uncertainties, the Company can give no assurances that its forward-looking statements will prove to be accurate, or that any other results or events projected or contemplated by its forward-looking statements will in fact occur, and the Company cautions investors not to place undue reliance on these statements. All forward-looking statements in this release represent the Company’s judgment as of February 10, 2020, and, except as otherwise required by law, the Company disclaims any obligation to update any forward-looking statements to conform the statement to actual results or changes in its expectations.

UNAUDITED CONSOLIDATED STATEMENTS OF INCOME

Three Months Ended

Year Ended

December 31,

December 31,

2019

2018

2019

2018

(In millions, except per-share amounts)

Revenue:

Premium revenue

$

4,123

$

4,438

$

16,208

$

17,612

Premium tax revenue

122

97

489

417

Health insurer fees reimbursed

81

329

Service revenue

16

407

Investment income and other revenue

29

32

132

125

Total revenue

4,274

4,664

16,829

18,890

Operating expenses:

Medical care costs

3,545

3,775

13,905

15,137

General and administrative expenses

343

335

1,296

1,333

Premium tax expenses

122

97

489

417

Health insurer fees

87

348

Depreciation and amortization

21

23

89

99

Restructuring costs

1

8

6

46

Cost of service revenue

15

364

Total operating expenses

4,032

4,340

15,785

17,744

Loss on sales of subsidiaries, net of gain

(52

)

(15

)

Operating income

242

272

1,044

1,131

Other expenses, net:

Interest expense

20

24

87

115

Other (income) expenses, net

(8

)

(15

)

17

Total other expenses, net

20

16

72

132

Income before income tax expense

222

256

972

999

Income tax expense

54

55

235

292

Net income

$

168

$

201

$

737

$

707

Net income per share, diluted

$

2.67

$

3.01

$

11.47

$

10.61

Diluted weighted average shares outstanding

63.0

66.6

64.2

66.6

Operating Statistics:

Medical care ratio

86.0

%

85.1

%

85.8

%

85.9

%

G&A ratio

8.0

%

7.2

%

7.7

%

7.1

%

Premium tax ratio

2.9

%

2.2

%

2.9

%

2.3

%

Effective income tax rate

24.3

%

21.4

%

24.2

%

29.2

%

After-tax margin

3.9

%

4.3

%

4.4

%

3.7

%

Medicaid

3.6

%

3.6

%

3.2

%

2.4

%

Medicare

5.5

%

8.0

%

6.7

%

4.8

%

Marketplace

4.5

%

15.4

%

10.3

%

16.4

%

CONSOLIDATED BALANCE SHEETS

December 31,

2019

2018

Unaudited

(Dollars in millions,
except per-share
amounts)

ASSETS

Current assets:

Cash and cash equivalents

$

2,452

$

2,826

Investments

1,946

1,681

Receivables

1,406

1,330

Prepaid expenses and other current assets

134

149

Derivative asset

29

476

Total current assets

5,967

6,462

Property, equipment, and capitalized software, net

385

241

Goodwill and intangible assets, net

172

190

Restricted investments

79

120

Deferred income taxes

79

117

Other assets

105

24

Total assets

$

6,787

$

7,154

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Medical claims and benefits payable

$

1,854

$

1,961

Amounts due government agencies

664

967

Accounts payable and accrued liabilities

455

390

Deferred revenue

249

211

Current portion of long-term debt

18

241

Derivative liability

29

476

Total current liabilities

3,269

4,246

Long-term debt

1,237

1,020

Finance lease liabilities

231

197

Other long-term liabilities

90

44

Total liabilities

4,827

5,507

Stockholders’ equity:

Common stock, $0.001 par value, 150 million shares authorized; outstanding: 62 million shares at each of December 31, 2019, and December 31, 2018

Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding

Additional paid-in capital

175

643

Accumulated other comprehensive income (loss)

4

(8

)

Retained earnings

1,781

1,012

Total stockholders’ equity

1,960

1,647

Total liabilities and stockholders' equity

$

6,787

$

7,154

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

Year Ended

December 31,

2019

2018

(In millions)

Operating activities:

Net income

$

737

$

707

Adjustments to reconcile net income to net cash provided by (used in) operating activities:

Depreciation and amortization

89

127

Deferred income taxes

10

(6

)

Share-based compensation

39

27

Amortization of convertible senior notes and finance lease liabilities

5

22

(Gain) loss on debt repayment

(15

)

22

Loss on sales of subsidiaries, net of gain

15

Non-cash restructuring costs

17

Other, net

(5

)

4

Changes in operating assets and liabilities:

Receivables

(76

)

(530

)

Prepaid expenses and other current assets

28

6

Medical claims and benefits payable

(107

)

(226

)

Amounts due government agencies

(303

)

(574

)

Accounts payable and accrued liabilities

2

45

Deferred revenue

38

(21

)

Income taxes

(15

)

51

Net cash provided by (used in) operating activities

427

(314

)

Investing activities:

Purchases of investments

(2,536

)

(1,444

)

Proceeds from sales and maturities of investments

2,302

2,445

Purchases of property, equipment, and capitalized software

(57

)

(30

)

Net cash received from sales of subsidiaries

190

Other, net

(2

)

(18

)

Net cash (used in) provided by investing activities

(293

)

1,143

Financing activities:

Repayment of principal amount of convertible senior notes

(240

)

(362

)

Cash paid for partial settlement of conversion option

(578

)

(623

)

Cash received for partial settlement of call option

578

623

Cash paid for partial termination of warrants

(514

)

(549

)

Proceeds from borrowings under term loan facility

220

Common stock purchases

(47

)

Repayment of credit facility

(300

)

Other, net

29

18

Net cash used in financing activities

(552

)

(1,193

)

Net decrease in cash, cash equivalents, and restricted cash and cash equivalents

(418

)

(364

)

Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period

2,926

3,290

Cash, cash equivalents, and restricted cash and cash equivalents at end of period

$

2,508

$

2,926

HEALTH PLANS SEGMENT MEMBERSHIP

As of December 31,

2019

2018

Ending Membership by Government Program:

Medicaid

2,956,000

3,361,000

Medicare

101,000

98,000

Marketplace

274,000

362,000

3,331,000

3,821,000

Ending Membership by Health Plan:

California

565,000

608,000

Florida (1)

132,000

313,000

Illinois

224,000

224,000

Michigan

362,000

383,000

New Mexico (1)

23,000

222,000

Ohio

288,000

302,000

Puerto Rico

176,000

252,000

South Carolina

131,000

120,000

Texas

341,000

423,000

Washington

832,000

781,000

Other (2)

257,000

193,000

3,331,000

3,821,000

__________________

(1) The Company’s Medicaid contracts in New Mexico and in all but two regions in Florida terminated in late 2018 and early 2019. The Company continues to serve Medicare and Marketplace members in both Florida and New Mexico, as well as Medicaid members in two regions in Florida.

(2) “Other” includes the Idaho, Mississippi, New York, Utah and Wisconsin health plans, which are not individually significant to the Company’s consolidated operating results.

HEALTH PLANS SEGMENT FINANCIAL DATA — BY GOVERNMENT PROGRAM

(In millions, except percentages)

Three Months Ended December 31,

2019

2018

Premium
Revenue

Medical
Care Costs

MCR (1)

Premium
Revenue

Medical
Care Costs

MCR (1)

Medicaid

$

3,227

$

2,818

87.3

%

$

3,430

$

3,046

88.8

%

Medicare

561

480

85.5

527

426

80.8

Marketplace

335

247

73.5

481

303

62.9

$

4,123

$

3,545

86.0

%

$

4,438

$

3,775

85.1

%

Year Ended December 31,

2019

2018

Premium
Revenue

Medical
Care Costs

MCR

Premium
Revenue

Medical
Care Costs

MCR

Medicaid

$

12,466

$

10,969

88.0

%

$

13,623

$

12,258

90.0

%

Medicare

2,243

1,913

85.3

2,074

1,752

84.5

Marketplace

1,499

1,023

68.2

1,915

1,127

58.9

$

16,208

$

13,905

85.8

%

$

17,612

$

15,137

85.9

%

__________________

(1) The MCR represents medical costs as a percentage of premium revenue.

CHANGE IN MEDICAL CLAIMS AND BENEFITS PAYABLE
(Dollars in millions)

The Company’s claims liability includes a provision for adverse claims deviation based on historical experience and other factors including, but not limited to, variations in claims payment patterns, changes in utilization and cost trends, known outbreaks of disease, and large claims. The Company’s reserving methodology is consistently applied across all periods presented. The amounts displayed for “Components of medical care costs related to: Prior period” represent the amount by which the original estimate of claims and benefits payable at the beginning of the period was more than the actual amount of the liability based on information (principally the payment of claims) developed since that liability was first reported. The following table presents the components of the change in medical claims and benefits payable for the periods indicated:

Year Ended December 31,

2019

2018

Medical claims and benefits payable, beginning balance

$

1,961

$

2,192

Components of medical care costs related to:

Current period

14,176

15,478

Prior period (1)

(271

)

(341

)

Total medical care costs

13,905

15,137

Change in non-risk and other provider payables

24

13

Payments for medical care costs related to:

Current period

12,554

13,671

Prior period

1,482

1,710

Total paid

14,036

15,381

Medical claims and benefits payable, ending balance

$

1,854

$

1,961

Days in claims payable, fee for service (2)

50

53

______________________

(1) The December 31, 2018, amounts include the 2018 benefit of the 2017 Marketplace CSR reimbursement of $81 million.

(2) Claims payable includes primarily IBNP. It also includes certain fee-for-service payables reported in “Other” medical claims and benefits payable amounting to $50 million and $43 million, as of December 31, 2019 and 2018, respectively.

UNAUDITED NON-GAAP FINANCIAL MEASURES

The Company uses non-generally accepted accounting principles, or non-GAAP, financial measures as supplemental metrics in evaluating the Company’s financial performance, making financing and business decisions, and forecasting and planning for future periods. For these reasons, management believes such measures are useful supplemental measures to investors in comparing the Company’s performance to the performance of other public companies in the health care industry. These non-GAAP financial measures should be considered as supplements to, and not as substitutes for or superior to, GAAP measures. See further information regarding non-GAAP measures below the tables.

Three Months Ended

Year Ended

December 31,

December 31,

2019

2018

2019

2018

(In millions)

Net income

$

168

$

201

$

737

$

707

Adjustments:

Depreciation, and amortization of intangible assets and capitalized software

21

23

89

118

Interest expense

20

24

87

115

Income tax expense

54

55

235

292

EBITDA

$

263

$

303

$

1,148

$

1,232

Adjustments made to GAAP measures used to calculate the non-GAAP measures used in this news release follow:

Earnings before interest, taxes, depreciation and amortization (“EBITDA”): Net income on a GAAP basis less depreciation, and amortization of intangible assets and capitalized software, interest expense and income tax expense. The Company believes that EBITDA is helpful in assessing the Company’s ability to meet the cash demands of its operating units.

UNAUDITED NON-GAAP FINANCIAL MEASURES CONTINUED

Three Months Ended December 31,

Year Ended December 31,

2019

2018

2019

2018

Amount

Per
Diluted
Share

Amount

Per
Diluted
Share

Amount

Per
Diluted
Share

Amount

Per
Diluted
Share

(In millions, except per diluted share amounts)

Net income

$

168

$

2.67

$

201

$

3.01

$

737

$

11.47

$

707

$

10.61

Adjustments:

Amortization of intangible assets

4

0.06

6

0.08

17

0.27

22

0.32

(Gain) loss on debt repayment

(3

)

(0.05

)

(15

)

(0.24

)

22

0.33

Restructuring costs

1

0.02

8

0.12

6

0.10

46

0.68

Loss on sales of subsidiaries, net of gain

52

0.78

15

0.23

Subtotal, adjustments

5

0.08

63

0.93

8

0.13

105

1.56

Income tax effect (1)

(1

)

(0.02

)

(23

)

(0.34

)

(2

)

(0.03

)

(30

)

(0.43

)

Adjustments, net of tax effect

4

0.06

40

0.59

6

0.10

75

1.13

Adjusted net income

$

172

$

2.73

$

241

$

3.60

$

743

$

11.57

$

782

$

11.74

________________________

(1) Income tax effect of adjustments calculated at the blended federal and state statutory tax rate of 22.6% and 22% for 2019 and 2018, respectively.

Adjustments made to GAAP measures used to calculate the non-GAAP measures used in this news release follow:

Adjusted net income: Net income on a GAAP basis less amortization of intangible assets, gain or loss on debt repayment, restructuring costs, loss on sales of subsidiaries, and the aggregate income tax effect calculated at the statutory tax rate. The Company believes that adjusted net income is helpful in assessing the Company’s financial performance exclusive of the non-cash impact of the amortization of purchased intangibles and the impact of certain expenses and other items that management believes are not indicative of longer-term business trends and operations.

Adjusted net income per diluted share: Adjusted net income divided by weighted average common shares outstanding on a fully diluted basis.

Beginning in the first quarter of 2020, the Company will no longer publish the tables that follow in its earnings announcements, through the last page of this news release.

HEALTH PLANS SEGMENT MEMBERSHIP

As of December 31,

2019

2018

Ending Membership by Government Program:

TANF and CHIP

1,987,000

2,295,000

Medicaid Expansion

605,000

660,000

ABD

364,000

406,000

Total Medicaid

2,956,000

3,361,000

MMP - Integrated

58,000

54,000

Medicare Special Needs Plans

43,000

44,000

Total Medicare

101,000

98,000

Total Medicaid and Medicare

3,057,000

3,459,000

Marketplace

274,000

362,000

3,331,000

3,821,000

UNAUDITED SELECTED FINANCIAL DATA

(In millions, except percentages and per-member per-month amounts)

HEALTH PLANS SEGMENT FINANCIAL DATA — BY GOVERNMENT PROGRAM

Member
Months (1)

Premium Revenue

Medical Care Costs

MCR (2)

Medical
Margin

Total

PMPM

Total

PMPM

Three Months Ended December 31, 2019

TANF and CHIP

6.1

$

1,244

$

206.74

$

1,117

$

185.79

89.9

%

$

127

Medicaid Expansion

1.8

720

395.37

608

333.59

84.4

112

ABD

1.1

1,263

1,150.24

1,093

995.29

86.5

170

Total Medicaid

9.0

3,227

361.16

2,818

315.41

87.3

409

MMP

0.2

396

2,284.37

343

1,981.07

86.7

53

Medicare

0.1

165

1,264.10

137

1,044.28

82.6

28

Total Medicare

0.3

561

1,846.15

480

1,578.71

85.5

81

Total Medicaid and Medicare

9.3

3,788

409.99

3,298

356.95

87.1

490

Marketplace

0.8

335

404.18

247

297.17

73.5

88

10.1

$

4,123

$

409.51

$

3,545

$

352.03

86.0

%

$

578

Three Months Ended December 31, 2018

TANF and CHIP

7.1

$

1,363

$

189.86

$

1,203

$

167.61

88.3

%

$

160

Medicaid Expansion

2.0

700

349.05

630

314.34

90.1

70

ABD

1.3

1,367

1,094.14

1,213

970.49

88.7

154

Total Medicaid

10.4

3,430

328.79

3,046

292.00

88.8

384

MMP

0.2

366

2,263.41

300

1,855.34

82.0

66

Medicare

0.1

161

1,206.96

126

944.65

78.3

35

Total Medicare

0.3

527

1,784.58

426

1,442.57

80.8

101

Total Medicaid and Medicare

10.7

3,957

368.93

3,472

323.72

87.7

485

Marketplace

1.1

481

437.79

303

275.56

62.9

178

11.8

$

4,438

$

375.33

$

3,775

$

319.24

85.1

%

$

663

Year Ended December 31, 2019

TANF and CHIP

24.4

$

4,838

$

198.66

$

4,258

$

174.88

88.0

%

$

580

Medicaid Expansion

7.2

2,775

383.93

2,418

334.53

87.1

357

ABD

4.4

4,853

1,111.09

4,293

982.83

88.5

560

Total Medicaid

36.0

12,466

346.79

10,969

305.16

88.0

1,497

MMP

0.7

1,589

2,346.87

1,377

2,033.77

86.7

212

Medicare

0.5

654

1,268.74

536

1,039.02

81.9

118

Total Medicare

1.2

2,243

1,880.79

1,913

1,603.73

85.3

330

Total Medicaid and Medicare

37.2

14,709

396.05

12,882

346.87

87.6

1,827

Marketplace

3.6

1,499

411.89

1,023

281.04

68.2

476

40.8

$

16,208

$

397.47

$

13,905

$

340.99

85.8

%

$

2,303

Year Ended December 31, 2018

TANF and CHIP

29.4

$

5,508

$

187.04

$

4,908

$

166.66

89.1

%

$

600

Medicaid Expansion

8.1

2,884

356.81

2,587

320.11

89.7

297

ABD

5.0

5,231

1,049.26

4,763

955.22

91.0

468

Total Medicaid

42.5

13,623

320.43

12,258

288.31

90.0

1,365

MMP

0.7

1,443

2,192.58

1,241

1,885.59

86.0

202

Medicare

0.5

631

1,180.46

511

955.81

81.0

120

Total Medicare

1.2

2,074

1,738.85

1,752

1,468.77

84.5

322

Total Medicaid and Medicare

43.7

15,697

359.14

14,010

320.53

89.2

1,687

Marketplace

4.9

1,915

392.97

1,127

231.33

58.9

788

48.6

$

17,612

$

362.54

$

15,137

$

311.59

85.9

%

$

2,475

__________________

(1) A member month is defined as the aggregate of each month’s ending membership for the period presented.

(2) The MCR represents medical costs as a percentage of premium revenue.

HEALTH PLANS SEGMENT FINANCIAL DATA — MEDICAID AND MEDICARE

Member
Months

Premium Revenue

Medical Care Costs

MCR

Medical
Margin

Total

PMPM

Total

PMPM

Three Months Ended December 31, 2019

California

1.5

$

531

$

334.81

$

414

$

261.66

78.2

%

$

117

Florida

0.3

125

426.72

109

371.79

87.1

16

Illinois

0.7

276

412.06

240

357.32

86.7

36

Michigan

1.0

390

362.57

321

298.90

82.4

69

Ohio

0.9

615

691.25

562

631.53

91.4

53

Puerto Rico

0.5

133

254.48

119

229.44

90.2

14

South Carolina

0.4

156

394.94

133

334.33

84.7

23

Texas

0.6

613

952.36

561

870.16

91.4

52

Washington

2.5

645

266.70

569

235.58

88.3

76

Other (1) (2)

0.9

304

406.59

270

360.51

88.7

34

9.3

$

3,788

$

409.99

$

3,298

$

356.95

87.1

%

$

490

Three Months Ended December 31, 2018

California

1.8

$

485

$

282.83

$

425

$

247.56

87.5

%

$

60

Florida

1.0

370

376.80

345

351.20

93.2

25

Illinois

0.7

242

361.29

196

291.63

80.7

46

Michigan

1.1

389

348.47

320

287.33

82.5

69

New Mexico (2)

0.6

305

489.86

265

425.85

86.9

40

Ohio

0.9

607

662.51

527

575.69

86.9

80

Puerto Rico

0.8

147

173.81

135

158.97

91.5

12

South Carolina

0.3

126

352.67

106

299.17

84.8

20

Texas

0.6

581

865.75

538

801.34

92.6

43

Washington

2.3

512

225.52

455

200.72

89.0

57

Other (1)

0.6

193

344.31

160

283.96

82.5

33

10.7

$

3,957

$

368.93

$

3,472

$

323.72

87.7

%

$

485

Year Ended December 31, 2019

California

6.4

$

2,039

$

313.75

$

1,700

$

261.74

83.4

%

$

339

Florida

1.3

543

414.29

483

368.81

89.0

60

Illinois

2.7

1,002

377.13

872

328.11

87.0

130

Michigan

4.3

1,589

368.73

1,311

304.22

82.5

278

Ohio

3.6

2,450

684.74

2,215

619.03

90.4

235

Puerto Rico

2.3

474

204.88

420

181.85

88.8

54

South Carolina

1.6

583

375.13

511

328.58

87.6

72

Texas

2.6

2,402

920.94

2,184

837.05

90.9

218

Washington

9.6

2,513

263.13

2,260

236.63

89.9

253

Other (1) (2)

2.8

1,114

403.47

926

335.31

83.1

188

37.2

$

14,709

$

396.05

$

12,882

$

346.87

87.6

%

$

1,827

Year Ended December 31, 2018

California

7.1

$

1,931

$

273.59

$

1,724

$

244.21

89.3

%

$

207

Florida

4.2

1,517

360.98

1,414

336.43

93.2

103

Illinois

2.5

793

322.87

670

272.61

84.4

123

Michigan

4.5

1,550

344.42

1,303

289.53

84.1

247

New Mexico (2)

2.6

1,241

474.10

1,140

435.65

91.9

101

Ohio

3.7

2,277

608.29

2,001

534.59

87.9

276

Puerto Rico

3.7

696

186.59

636

170.45

91.4

60

South Carolina

1.4

495

351.38

429

304.85

86.8

66

Texas

2.7

2,296

839.70

2,092

765.12

91.1

204

Washington

9.1

2,178

240.42

1,999

220.72

91.8

179

Other (1)

2.2

723

329.06

602

273.55

83.1

121

43.7

$

15,697

$

359.14

$

14,010

$

320.53

89.2

%

$

1,687

_______________

(1) “Other” includes the Idaho, Mississippi, New York, Utah and Wisconsin health plans, which are not individually significant to the Company’s consolidated operating results.

(2) In 2019, “Other” includes the New Mexico health plan. The New Mexico health plan’s Medicaid contract terminated on December 31, 2018, and therefore its 2019 results are not individually significant to the Company’s consolidated operating results.

HEALTH PLANS SEGMENT FINANCIAL DATA — MARKETPLACE

Member
Months

Premium Revenue

Medical Care Costs

MCR

Medical
Margin

Total

PMPM

Total

PMPM

Three Months Ended December 31, 2019

California

0.2

$

53

$

365.16

$

36

$

241.93

66.3

%

$

17

Florida

0.1

39

357.79

26

239.09

66.8

13

Michigan

0.1

8

497.43

5

302.84

60.9

3

Ohio

24

803.58

18

599.84

74.6

6

Texas

0.4

132

337.02

99

253.66

75.3

33

Washington

39

684.31

33

563.25

82.3

6

Other (1)

40

492.23

30

379.25

77.0

10

0.8

$

335

$

404.18

$

247

$

297.17

73.5

%

$

88

Three Months Ended December 31, 2018

California

$

48

$

322.39

$

36

$

248.84

77.2

%

$

12

Florida

0.1

62

526.44

32

278.60

52.9

30

Michigan

0.1

11

259.20

8

166.54

64.3

3

New Mexico

0.1

22

328.32

19

302.79

92.2

3

Ohio

0.1

27

512.33

20

366.62

71.6

7

Texas

0.7

269

440.81

153

250.66

56.9

116

Washington

44

697.31

35

536.80

77.0

9

Other (2)

(2

)

NM

NM

NM

(2

)

1.1

$

481

$

437.79

$

303

$

275.56

62.9

%

$

178

Year Ended December 31, 2019

California

0.7

$

227

$

364.82

$

137

$

218.06

59.8

%

$

90

Florida

0.5

191

382.52

107

214.19

56.0

84

Michigan

0.1

35

479.12

20

273.87

57.2

15

Ohio

0.1

103

802.29

71

556.15

69.3

32

Texas

1.7

589

342.57

430

250.40

73.1

159

Washington

0.2

182

730.31

130

522.15

71.5

52

Other (1)

0.3

172

494.05

128

368.08

74.5

44

3.6

$

1,499

$

411.89

$

1,023

$

281.04

68.2

%

$

476

Year Ended December 31, 2018

California

0.6

$

219

$

325.84

$

125

$

187.37

57.5

%

$

94

Florida

0.6

273

498.66

99

181.52

36.4

174

Michigan

0.2

51

250.69

31

150.11

59.9

20

New Mexico

0.3

115

403.55

74

260.29

64.5

41

Ohio

0.3

111

477.03

78

334.32

70.1

33

Texas

2.7

948

356.06

593

222.89

62.6

355

Washington

0.2

183

664.48

140

506.07

76.2

43

Other (2)

15

NM

(13

)

NM

NM

28

4.9

$

1,915

$

392.97

$

1,127

$

231.33

58.9

%

$

788

__________________

(1) “Other” includes the New Mexico, Utah and Wisconsin health plans, which are not individually significant to the Company’s consolidated operating results in 2019.

(2) “Other” includes the Utah and Wisconsin health plans, where the Company did not participate in the Marketplace in 2018. Therefore, the ratios for 2018 periods are not meaningful (NM).

HEALTH PLANS SEGMENT FINANCIAL DATA — TOTAL

Member
Months

Premium Revenue

Medical Care Costs

MCR

Medical
Margin

Total

PMPM

Total

PMPM

Three Months Ended December 31, 2019

California

1.7

$

584

$

337.37

$

450

$

259.99

77.1

%

$

134

Florida

0.4

164

407.98

135

335.71

82.3

29

Illinois

0.7

276

412.06

240

357.32

86.7

36

Michigan

1.1

398

364.51

326

298.95

82.0

72

Ohio

0.9

639

694.87

580

630.51

90.7

59

Puerto Rico

0.5

133

254.48

119

229.44

90.2

14

South Carolina

0.4

156

394.94

133

334.33

84.7

23

Texas

1.0

745

720.66

660

638.02

88.5

85

Washington

2.5

684

276.64

602

243.37

88.0

82

Other (1) (2)

0.9

344

414.93

300

362.34

87.3

44

10.1

$

4,123

$

409.51

$

3,545

$

352.03

86.0

%

$

578

Three Months Ended December 31, 2018

California

1.8

$

533

$

285.98

$

461

$

247.66

86.6

%

$

72

Florida

1.1

432

392.68

377

343.49

87.5

55

Illinois

0.7

242

361.29

196

291.63

80.7

46

Michigan

1.2

400

344.96

328

282.58

81.9

72

New Mexico (2)

0.7

327

474.44

284

414.10

87.3

43

Ohio

1.0

634

654.39

547

564.37

86.2

87

Puerto Rico

0.8

147

173.81

135

158.97

91.5

12

South Carolina

0.3

126

352.67

106

299.17

84.8

20

Texas

1.3

850

663.84

691

539.68

81.3

159

Washington

2.3

556

238.21

490

209.76

88.1

66

Other (1)

0.6

191

344.44

160

285.37

82.9

31

11.8

$

4,438

$

375.33

$

3,775

$

319.24

85.1

%

$

663

Year Ended December 31, 2019

California

7.1

$

2,266

$

318.22

$

1,837

$

257.91

81.0

%

$

429

Florida

1.8

734

405.52

590

326.11

80.4

144

Illinois

2.7

1,002

377.13

872

328.11

87.0

130

Michigan

4.4

1,624

370.57

1,331

303.71

82.0

293

Ohio

3.7

2,553

688.80

2,286

616.86

89.6

267

Puerto Rico

2.3

474

204.88

420

181.85

88.8

54

South Carolina

1.6

583

375.13

511

328.58

87.6

72

Texas

4.3

2,991

691.31

2,614

604.14

87.4

377

Washington

9.8

2,695

275.05

2,390

243.91

88.7

305

Other (1) (2)

3.1

1,286

413.61

1,054

338.98

82.0

232

40.8

$

16,208

$

397.47

$

13,905

$

340.99

85.8

%

$

2,303

Year Ended December 31, 2018

California

7.7

$

2,150

$

278.13

$

1,849

$

239.28

86.0

%

$

301

Florida

4.8

1,790

376.84

1,513

318.58

84.5

277

Illinois

2.5

793

322.87

670

272.61

84.4

123

Michigan

4.7

1,601

340.35

1,334

283.47

83.3

267

New Mexico (2)

2.9

1,356

467.17

1,214

418.44

89.6

142

Ohio

4.0

2,388

600.62

2,079

522.89

87.1

309

Puerto Rico

3.7

696

186.59

636

170.45

91.4

60

South Carolina

1.4

495

351.38

429

304.85

86.8

66

Texas

5.4

3,244

601.23

2,685

497.75

82.8

559

Washington

9.3

2,361

252.92

2,139

229.13

90.6

222

Other (1)

2.2

738

336.86

589

268.17

79.6

149

48.6

$

17,612

$

362.54

$

15,137

$

311.59

85.9

%

$

2,475

__________________

(1) “Other” includes the Idaho, Mississippi, New York, Utah and Wisconsin health plans, which are not individually significant to the Company’s consolidated operating results.

(2) In 2019, “Other” includes the New Mexico health plan. The New Mexico health plan’s Medicaid contract terminated on December 31, 2018, and therefore its 2019 results are not individually significant to the Company’s consolidated operating results.

SELECTED FINANCIAL DATA

The following table provides details of the Company’s medical care costs for the periods indicated:

Three Months Ended December 31,

2019

2018

Amount

PMPM

% of
Total

Amount

PMPM

% of
Total

Fee for service

$

2,660

$

264.20

75.0

%

$

2,807

$

237.39

74.4

%

Pharmacy

427

42.43

12.0

493

41.68

13.1

Capitation

293

29.06

8.3

293

24.83

7.7

Other

165

16.34

4.7

182

15.34

4.8

$

3,545

$

352.03

100.0

%

$

3,775

$

319.24

100.0

%

Year Ended December 31,

2019

2018

Amount

PMPM

% of
Total

Amount

PMPM

% of
Total

Fee for service

$

10,453

$

256.34

75.1

%

$

11,278

$

232.15

74.5

%

Pharmacy

1,681

41.23

12.1

2,138

44.01

14.1

Capitation

1,149

28.17

8.3

1,184

24.38

7.8

Other

622

15.25

4.5

537

11.05

3.6

$

13,905

$

340.99

100.0

%

$

15,137

$

311.59

100.0

%

The following table provides details of the Company’s medical claims and benefits payable as of the dates indicated:

December 31,

2019

2018

Fee-for-service claims incurred but not paid (IBNP)

$

1,406

$

1,562

Pharmacy payable

126

115

Capitation payable

55

52

Other (1)

267

232

$

1,854

$

1,961

______________________

(1) “Other” medical claims and benefits payable include amounts payable to certain providers for which the Company acts as an intermediary on behalf of various state agencies without assuming financial risk. Such receipts and payments do not impact the Company’s consolidated statements of income. As of December 31, 2019 and 2018, the Company had recorded non-risk provider payables of approximately $132 million and $107 million, respectively.

SUMMARY OF NON-RUN RATE ITEMS AFFECTING CURRENT QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS

(In millions, except per diluted share amounts)

The table below summarizes the impact of certain expenses and other items that management believes are not indicative of longer-term business trends and operations. The individual items presented below increase (decrease) income before income tax expense.

Three Months Ended December 31,

Year Ended December 31,

2019

2018

2019

2018

Amount

Per
Diluted
Share (1)

Amount

Per
Diluted
Share (1)

Amount

Per
Diluted
Share (1)

Amount

Per
Diluted
Share (1)

Gain (loss) on debt repayment

$

$

$

3

$

0.04

$

15

$

0.18

$

(22

)

$

(0.29

)

Restructuring costs

(1

)

(0.01

)

(8

)

(0.09

)

(6

)

(0.07

)

(46

)

(0.54

)

Loss on sales of subsidiaries, net of gain

(52

)

(0.48

)

(15

)

(0.05

)

$

(1

)

$

(0.01

)

$

(57

)

$

(0.53

)

$

9

$

0.11

$

(83

)

$

(0.88

)

______________________

(1) Except for permanent differences between GAAP and tax (such as certain expenses that are not deductible for tax purposes), per diluted share amounts are generally calculated at the statutory income tax rate of 22.6% and 22% for 2019 and 2018, respectively.

NON-GAAP FINANCIAL MEASURES

Three Months Ended December 31,

Year Ended December 31,

2019

2018

2019

2018

Amount

Per
Diluted
Share

Amount

Per
Diluted
Share

Amount

Per
Diluted
Share

Amount

Per
Diluted
Share

Net income

$

168

$

2.67

$

201

$

3.01

$

737

$

11.47

$

707

$

10.61

Adjustment:

Amortization of intangible assets

4

0.06

6

0.08

17

0.27

22

0.32

Income tax effect (1)

(1

)

(0.01

)

(1

)

(0.02

)

(4

)

(0.06

)

(5

)

(0.07

)

Adjustment, net of tax effect

3

0.05

5

0.06

13

0.21

17

0.25

Adjusted net income

$

171

$

2.72

$

206

$

3.07

$

750

$

11.68

$

724

$

10.86

________________________

(1) Income tax effect of adjustments calculated at the blended federal and state statutory tax rate of 22.6% and 22% for 2019 and 2018, respectively.

Adjustments made to GAAP measures used to calculate the non-GAAP measures used in this news release follow:

Adjusted net income: Net income on a GAAP basis less amortization of intangible assets, net of income tax effect calculated at the statutory tax rate. The Company believes that adjusted net income is helpful in assessing the Company’s financial performance exclusive of the non-cash impact of the amortization of purchased intangibles.

Adjusted net income per diluted share: Adjusted net income divided by weighted average common shares outstanding on a fully diluted basis.

Investor Contact: Julie Trudell, [email protected], 562-912-6720

Media Contact: Caroline Zubieta, [email protected], 562-951-1588

Source: Molina Healthcare, Inc.

Categories

Business Wire Press Releases

Next Articles